- Progressive pulmonary fibrosis following BCNU treatment
-
Chung T, Sung IK
- KMID: 1742167
- J Korean Cancer Assoc.
- 1992 Jun;24(3):463-468.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Mycosis Fungoides
-
Jeong SW, Chun JH, Cha SH, Park SD
- KMID: 2232169
- Korean J Dermatol.
- 1999 Sep;37(9):1364-1366.
We describe a case of mycosis fungoides (infiltrative plaque type) in an 86-year-old male. He had experienced dark erythematous round plaques on the face, trunk, buttock, upper and lower extremities.... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy of the Malignant Gliomas
-
Choi MS
- KMID: 2068179
- J Korean Neurosurg Soc.
- 1984 Jun;13(2):245-248.
The outlook for patients with malignant gliomas of the brain remains rather poor. However, after many experience of decades, the data indicate that some improvements seemed to have occurred with... -
- CITED
-
- Close
- SHARE
-
- Close
- BCNU-CDDP Continuous Infusion Chemotherapy in Recurrent Oligodendroglioma
-
Youn SM, Rhee CH, Lee SH, Song JW, Kim JH
- KMID: 2010232
- J Korean Neurosurg Soc.
- 1996 Mar;25(3):540-543.
Eight patients with recurrent oligodendroglioma were treated with 1.3-bis(2-chloroethyl) nitrosourea(BCNU) and CDD continuous infusion chemotherapy. They were 5 with benign oligodendrogliomas and 3 with anaplastic oligodendrogliomas. All the recurrent tumors... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of the Early Mycosis Fungoides
-
Shin HS, Huh CH, Cho KH
- KMID: 2302130
- Korean J Dermatol.
- 2007 Oct;45(10):983-988.
BACKGROUND: Mycosis fungoides (MF) is the most frequent form of cutaneous lymphoma. Early stage MF is known to be responsible to the various topical and systemic therapies. However, there have... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravenous vs Selective Intraarterial ACNU Chemotherapy on Malignant Gliomas
-
Kim JH
- KMID: 1673415
- J Korean Neurosurg Soc.
- 1990 May;19(5):637-645.
In 17 cases of glioblastoma multiforme and 3 cases of anaplastic astrocytoma, ACNU chemotherapy was performed by intravenous(10 cases) and supraophthalmic or superselective intraarterial(10 cases) injection postoperatively combined with radiation... -
- CITED
-
- Close
- SHARE
-
- Close
- Models of Experimental Brain Tumors
-
Ha YS
- KMID: 2068178
- J Korean Neurosurg Soc.
- 1984 Jun;13(2):237-244.
Despite concentrated basic and clinical research efforts including the initial successful combination of surgery, radiotherapy and chemotherapy with BCNU, significant progress in the treatment of human brain tumors have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
-
Shabbir-Moosajee M, Jehangir S, Sawani S, Muhammed T, Ali N, Sheikh U, Adil S
- KMID: 2451010
- Blood Res.
- 2019 Jun;54(2):108-113.
- doi: 10.5045/br.2019.54.2.108
BACKGROUND: Bendamustine is an attractive option for the management of both de novo and relapsed lymphomas. It is being increasingly used in the conditioning regimen for autologous stem cell transplantation... -
- CITED
-
- Close
- SHARE
-
- Close
- An Analysis of Combined interferon-beta, BCNU and Radiation in the Treatment of Malignant Glioma
-
Kye DK, Park YS, Cho KK, Lee KJ, Park SC, Choi CR
- KMID: 1955058
- J Korean Neurosurg Soc.
- 1995 Dec;24(12):1480-1485.
Prognosis for patients with a malignant glioma of the brain is, up to the present time, very poor. Surgery is unlikely to be curative and the primary goals of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Modulation of Cytotoxicity by Nitric Oxide Donors during Treatment of Glioma with Anticancer Drugs
-
Park JJ, Kang JS, Lee HS, Lee JS, Lee YH, Youm JY
- KMID: 1882179
- J Korean Neurosurg Soc.
- 2005 Nov;38(5):366-374.
OBJECTIVE: Nitric oxide(NO) is implicated in a wide range of biological processes in tumors and is produced in glioma. To investigate the role of NO and its interaction with the... -
- CITED
-
- Close
- SHARE
-
- Close
- Three Cases Treated with High-dose Cytarabine and Etoposide followed by Autologous Stem Cell Transplantation for Relapsed Primary CNS Lymphoma
-
Koo JE, Ryu MH, Shon HJ, Kang HJ, Kim WK, Suh C, Lee JS, Kang YK
- KMID: 1610811
- Korean J Hematol.
- 2005 Sep;40(3):172-176.
- doi: 10.5045/kjh.2005.40.3.172
The treatment outcomes with conventional second-line chemotherapy or radiotherapy aregenerally very poor for patients with relapsed primary CNS lymphoma (PCNSL). We treated three relapsed PCNSL patients with high-dose cytarabine plus... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation for Children with Acute Myelogenous Leukemia in Korea
-
Shin EY
- KMID: 2278213
- Korean J Pediatr Hematol Oncol.
- 2001 Apr;8(1):9-16.
PURPOSE: Autografts with peripheral blood stem cells (PBSCT) have become an accepted alternative to bone marrow transplantation for restoring hematopoiesis after marrow ablative therapy. METHODS: Questionnaires are given to all... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Toxicity Following High-Dose Chemotherapy With Peripheral Blood Stem Cell Transplantation
-
Lee SM, Park KJ, Oh YJ, Cheong SC, Hwang SC, Lee YH, Kim HS, Lim HY, Kim HC, Yim H, Hahn MH
- KMID: 2050162
- Tuberc Respir Dis.
- 1999 Jul;47(1):77-89.
- doi: 10.4046/trd.1999.47.1.77
BACKGROUND: High-dose chemotherapy is increasingly employed in many refractory malignant diseases. This therapy has been reported to increase response rate and survival benefits but it is also associated with higher... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Treatment-Related Myelodysplastic syndrome and Acute Myelogenous Leukemia Following High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Non-Hodgkin's Lymphoma
-
Jang GD, Kim SW, Suh CW, Kim EK, Bahng HS, Jeong YH, Park IG, Kim WK, Kim SH, Suh EJ, Park CJ, Ji HS, Lee JS
- KMID: 1109769
- J Korean Med Sci.
- 2002 Aug;17(4):555-559.
- doi: 10.3346/jkms.2002.17.4.555
Treatment-related myelodysplastic syndrome (t-MDS) and acute myelogenous leukemia (t-AML) are now well established as complications of cytotoxic chemotherapy. We experienced a 28-yr-old female patient who developed t-MDS/t-AML with characteristic chromosomal... -
- CITED
-
- Close
- SHARE
-
- Close
